Wednesday, October 18, 2017 2:25:21 PM
Pluristem States That They Can Produce 150,000 Doses per Year Of PLX-Cells. One Must Remember That It Is The Bioreactor That Determines How Many Doses They Can Make. Therefore When They Make That Statement It Is Because They Only Need Enough Doses For Clinical Trials. It's Not The Size Of The Building But The Size Of The Bioreactors.
Pluristem Has Been Very Vague In Explaining To The Public That In Order To Scale-Up Production All They Have To Do Is Change From Their Current 15 Liter Bioreactors Making 150,000 Dose Per Year To A 50 Liter Bioreactors Making Approximately 500,000 Dose Per Year. I Don't Think People Realize That Scaling-Up Production Only Means Using Larger Bioreactors. We Now Know As Of September 5th, From The You-Tube Video Below That They Have Already Scaled-up To 50 Liter Bioreactors. My Guess Is, They Are Aiming For At Least 1 Million Doses Per Year From Their Haifa Facility ?
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM